{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Severe hypertriglyceridaemia",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_gemfibrozil",
          "name": "Gemfibrozil"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_fenofibrate",
          "name": "Fenofibrate"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_clofibrate",
          "name": "Clofibrate"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_estrogens",
          "name": "Estrogens"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_thiazolidinediones",
          "name": "Thiazolidinediones"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_sodium_glucose_cotransporter_2_inhibitors",
          "name": "Sodium-glucose cotransporter-2 inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_bosentan",
          "name": "Bosentan"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_glitazones",
          "name": "Glitazones"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_beta_blockers",
          "name": "Beta-blockers"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_progestins",
          "name": "Progestins"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [],
    "ranking": [],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_gemfibrozil",
          "type": "Drug",
          "label": "Gemfibrozil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_fenofibrate",
          "type": "Drug",
          "label": "Fenofibrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_clofibrate",
          "type": "Drug",
          "label": "Clofibrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_niacin",
          "type": "Drug",
          "label": "Niacin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_estrogens",
          "type": "Drug",
          "label": "Estrogens",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thiazolidinediones",
          "type": "Drug",
          "label": "Thiazolidinediones",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sodium_glucose_cotransporter_2_inhibitors",
          "type": "Drug",
          "label": "Sodium-glucose cotransporter-2 inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_bosentan",
          "type": "Drug",
          "label": "Bosentan",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_glitazones",
          "type": "Drug",
          "label": "Glitazones",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_beta_blockers",
          "type": "Drug",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_progestins",
          "type": "Drug",
          "label": "Progestins",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_severe_hypertriglyceridaemia",
          "type": "Disease",
          "label": "Severe hypertriglyceridaemia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_ppar_alpha",
          "type": "Target",
          "label": "PPAR-alpha",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_ppar_gamma",
          "type": "Target",
          "label": "PPAR-gamma",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_lipid_metabolism",
          "type": "Pathway",
          "label": "Lipid Metabolism",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot",
          "type": "Target",
          "label": "Off-targets of Gemfibrozil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp",
          "type": "Pathway",
          "label": "Risk Pathway leading to adverse effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv",
          "type": "Phenotype",
          "label": "Adverse effects due to Drug Interaction",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Gemfibrozil",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Fenofibrate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Clofibrate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Niacin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Estrogens",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Thiazolidinediones",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Sodium-glucose cotransporter-2 inhibitors",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Bosentan",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Glitazones",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Progestins",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_gemfibrozil",
          "target": "target_ppar_alpha",
          "relation": "activates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Gemfibrozil活化PPAR-alpha，常用于高甘油三酯血症"
        },
        {
          "source": "drug_fenofibrate",
          "target": "target_ppar_alpha",
          "relation": "activates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Fenofibrate通过激活PPAR-alpha降低甘油三酯"
        },
        {
          "source": "drug_clofibrate",
          "target": "target_ppar_alpha",
          "relation": "activates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Clofibrate已知激活PPAR-alpha"
        },
        {
          "source": "drug_niacin",
          "target": "pathway_lipid_metabolism",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Niacin影响脂质代谢通路，降低甘油三酯"
        },
        {
          "source": "drug_estrogens",
          "target": "target_ppar_gamma",
          "relation": "activates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Estrogens可能激活PPAR-gamma影响脂质"
        },
        {
          "source": "drug_thiazolidinediones",
          "target": "target_ppar_gamma",
          "relation": "activates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Thiazolidinediones激活PPAR-gamma，相关脂质代谢"
        },
        {
          "source": "drug_sodium_glucose_cotransporter_2_inhibitors",
          "target": "disease_severe_hypertriglyceridaemia",
          "relation": "associated_with",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "相关研究显示SGLT-2抑制剂与甘油三酯影响"
        },
        {
          "source": "drug_corticosteroids",
          "target": "disease_severe_hypertriglyceridaemia",
          "relation": "associated_with",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Corticosteroids已知引发高甘油三酯"
        },
        {
          "source": "drug_bosentan",
          "target": "disease_severe_hypertriglyceridaemia",
          "relation": "associated_with",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Bosentan可能与甘油三酯调节有关"
        },
        {
          "source": "drug_glitazones",
          "target": "target_ppar_gamma",
          "relation": "activates",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Glitazones激活PPAR-gamma，参与脂质代谢"
        },
        {
          "source": "drug_beta_blockers",
          "target": "disease_severe_hypertriglyceridaemia",
          "relation": "associated_with",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "部分研究表明β阻滞剂影响甘油三酯"
        },
        {
          "source": "drug_progestins",
          "target": "disease_severe_hypertriglyceridaemia",
          "relation": "associated_with",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Progestins可能影响甘油三酯代谢"
        },
        {
          "source": "drug_gemfibrozil",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能影响肝脏代谢导致高甘油三酯血症"
        },
        {
          "source": "n_ot",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "肝脏受影响，增加副作用风险"
        },
        {
          "source": "n_rp",
          "target": "n_adv",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "导致不良表型，如胰腺炎"
        },
        {
          "source": "n_adv",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若风险成立，抵消 Gemfibrozil 的获益"
        }
      ],
      "round_index": 2
    },
    "history": {
      "round": 2
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_gemfibrozil",
          "name": "Gemfibrozil"
        },
        "score": 0.54,
        "graph_snapshot_ref": "GE_H1_round2",
        "key_assumptions": [
          "Gemfibrozil可激活PPAR-alpha，但面临与肝脏代谢相关的副作用风险",
          "风险路径可能导致严重不良表型"
        ],
        "caveats": [
          "推荐剂量下安全性与获益的平衡尚不明确"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_fenofibrate",
          "name": "Fenofibrate"
        },
        "score": 0.5,
        "graph_snapshot_ref": "GE_H2_round2",
        "key_assumptions": [
          "Fenofibrate通过激活PPAR-alpha有潜在获益",
          "缺乏有效证据表示与副作用直接相关"
        ],
        "caveats": [
          "与其他药物可能存在相互作用"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_clofibrate",
          "name": "Clofibrate"
        },
        "score": 0.48,
        "graph_snapshot_ref": "GE_H3_round2",
        "key_assumptions": [
          "Clofibrate的作用机制与PPAR-alpha相关，但未完全清晰",
          "尚缺乏在大规模研究中的安全性验证"
        ],
        "caveats": [
          "需关注与其他用药的相互作用风险"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Target(通路)→不良反应",
          "reason": "多条连接证据指向Gemfibrozil可能的副作用"
        }
      ],
      "remaining_gaps": [
        "对各个假设的安全性与疗效进行进一步验证"
      ]
    },
    "seed_retrospective": {
      "batches": [],
      "lessons": [
        "在考虑联合药物使用时，需全面评估潜在风险与获益"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "优化Gemfibrozil的剂量与使用条件以最大化疗效，最小化副作用"
      },
      {
        "role": "Skeptic",
        "patch": "强调Gemfibrozil所可能造成的肝脏代谢负担"
      }
    ],
    "heuristics": [
      {
        "when": "严重高甘油三酯血症",
        "then": "优先评估药物间相互作用与个体化治疗"
      }
    ]
  }
}